Stanford University
Showing 1,201-1,220 of 1,596 Results
-
Maria Grazia Roncarolo
George D. Smith Professor of Stem Cell and Regenerative Medicine, Emerita
Current Research and Scholarly InterestsResearch Interests
Immunetolerance: Mechanisms underlying T-cell tolerance, induction of T-cell anergy and regulatory T cells; Immunomodulation: mAbs, proteins and low molecular weight compounds which can modulate T-cell activation; Primary immunodeficiencies: Characterization of molecular and immunological defects; Gene therapy: Gene transduction of hematopoietic cells for gene therapy in primary immunodeficiencies and metabolic diseases; Hematopoiesis: Mechanisms underlying growth and differentiation of hematopoietic stem cells; Transplantation: Immune reconstitution and T-cell tolerance after allogenic stem cell transplantation; Cytokines/Cytokine receptors: Role in regulation of immune and inflammatory responses
Clinical Interests
Primary Immunodeficiencies
Monogenic Autoimmune Disorders
Allogenic Bone Marrow Transplantation
Gene Therapy Clinical Trials
Cell Therapy Clinical Trials
Clinical Trials in Autoimmune Diseases and Organ Transplantation
Clinical Trials in Hemoglobinopathies -
Andrew Rong, MD
Associate Professor of Ophthalmology (Research/Clinical Trials)
BioDr. Andrew J. Rong is a board-certified, fellowship-trained oculofacial plastic, reconstructive, and orbital surgeon with Stanford Health Care. He is also an associate professor in the Department of Ophthalmology, Division of Oculoplastic, Reconstructive, and Orbital Surgery at Stanford University School of Medicine.
Dr. Rong has extensive expertise in cosmetic, functional, and reconstructive eyelid surgery. He specializes in upper and lower blepharoplasty, ptosis repair, revision eyelid surgery, brow lifting, and natural-looking periocular rejuvenation. He also treats eyelid tumors, eyelid malposition, thyroid eye disease, orbital tumors, and other complex conditions affecting the eyelids and eye socket. Dr. Rong performs advanced eyelid and periocular reconstruction following trauma, cancer treatment, and previous surgery. Whether performing cosmetic or reconstructive eyelid surgery, he provides individualized care designed to preserve eyelid function while achieving balanced, natural-looking results.
Dr. Rong graduated summa cum laude from the University of California, Los Angeles, with a degree in Microbiology, Immunology, and Molecular Genetics. He received his medical degree from the University of California, Davis, where he was elected to the Alpha Omega Alpha Honor Medical Society. He completed both his ophthalmology residency and oculoplastic surgery fellowship at Bascom Palmer Eye Institute. He subsequently joined the faculty at Bascom Palmer and served as Director of the Oculoplastic, Reconstructive, and Orbital Surgery Division, leading one of the country’s largest academic oculoplastic surgery services before returning to his native California and joining Stanford.
A major focus of Dr. Rong’s academic work is oculoplastic oncology, particularly sebaceous carcinoma of the ocular adnexa. His research seeks to improve how eyelid and periocular cancers are detected, characterized, and treated through molecular diagnostics, biomarker discovery, and translational laboratory models. His work has advanced the understanding of sebaceous carcinoma biology, including the identification of novel diagnostic markers and investigation of emerging therapeutic approaches. Dr. Rong has also developed and published innovative surgical techniques for complex eyelid, ocular surface, orbital, and periocular reconstruction, including reconstruction following lacrimal and periocular tumor resection.
Dr. Rong has authored numerous peer-reviewed publications, abstracts, and book chapters. He has lectured nationally and internationally on eyelid and periocular cancers, sebaceous carcinoma, ocular surface reconstruction, orbital surgery, cosmetic oculofacial surgery, and complex oculoplastic techniques. His research has been supported by grant and philanthropic funding and published in leading ophthalmology journals.
Dr. Rong is a member of the American Society of Ophthalmic Plastic and Reconstructive Surgery and has been recognized as a Castle Connolly Top Doctor. Outside of medicine, he enjoys spending time with his wife and two young daughters. -
Samantha Noel Ronjak
Graduate, Stanford Center for Professional Development
BioSam is a Principal UX Designer at RTX, where she works on enterprise software for complex technical systems. She is pursuing a graduate certificate in Human-Computer Interaction at Stanford to deepen her technical foundation and expand her research practice. Her background spans human-centered design and renewable energy, and she currently serves on the board of the American Solar Energy Society.
-
Morteza Roodgar DVM, PhD
Veterinarian Research Scientist, Genetics
BioDr. Morteza Roodgar is a veterinarian scientist with a research focus on Primate induced Pluripotent Stem Cells (iPSCs) and long-read genomics tools.
Dr. Roodgar's research focus is on primate stem cell biology, immunology, and comparative genomics of nonhuman primate models for human diseases. The long-term goal of Dr. Roodgar's research is to Replace, Reduce and Refine (aka 3 R’s) the use of animals in biomedical research leveraging primate induced pluripotent stem cells (iPSCs) and long-read genomic tools to speed up preclinical testing.
Previous research includes immunology and genomic susceptibility to infectious diseases (e.g., tuberculosis, TB) in nonhuman primate models, Preventive Veterinary Medicine and emerging zoonotic diseases (e.g., COVID-19 and Monkeypox). -
Aaron Roodman
Professor of Particle Physics and Astrophysics
BioAaron Roodman is a professor of Particle Physics & Astrophysics at the SLAC National Accelerator Laboratory, specializing in observational cosmology. Trained in experimental particle physics, he spent two decades studying differences between Matter and antiMatter, before turning his research to astrophysics and cosmology. Roodman’s current research focuses on the study of Dark Energy using images from the Vera C. Rubin Observatory. He has played a major role in the construction of the LSST Camera, the world's largest digital camera, and is currently the leader of the LSST Camera program and Deputy Director of the Rubin Observatory for construction.
-
Michal Bental Roof
Academic Prog Prof 3, Pediatrics - Cardiology
Current Role at StanfordI joined the Cardiopulmonary Research Program of Drs. Rabinovitch and Bland at Stanford University in 2002, as the Academic and Research Program Officer, and since 2020 assumed my role at the Basic Science and Engineering (BASE) Initiative at the Betty Irene Moore Children's Heart Center, directed by Dr. Rabinovitch. I organize the educational activities of the lab, and assist the faculty and fellows with the preparation of grant proposals, IRB, APLAC and Biosafety protocols, manuscripts, and presentations. I served as the Site Coordinator for the Stanford Transplant Procurement Center of the Pulmonary Hypertension Breakthrough Initiative (PHBI), headed by Dr. Rabinovitch,that now evolved into the Stanford Transplant Tissue Bank. In this capacity, I oversee patient recruitment, data collection and reporting, and ensure compliance with university and federal guidelines. I coordinated and prepared the application for an Investigational New Drug (IND) and the pre-IND meeting that preceded that, for Elafin as a therapy for pulmonary arterial hypertension (PAH) to the FDA in August 2017, and with the Study PIs coordinated the Phase 1 clinical trial “Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects” that followed.
From 2005-2015, I served as the Administrative Coordinator of the Cardiovascular and Pulmonary Science Scholarly Concentration for medical students at Stanford University School of Medicine. This includes facilitating communication of the four co-Directors with the School of Medicine Administration, the medical students, and the faculty mentors. An important component of this role is the coordination of the MED223 course, a medical school course where faculty and fellows present new developments in cardiovascular science in the form of a journal club. From 2013-2018, I was the coordinator for the NIH-NHLBI T32 “Mechanisms and Innovation in Vascular Disease” (PI: RL Dalman), and from 2013 to date for NIH-NHLBI K12 HL120001 “Stanford Career Development Program in ‘Omics’ of Lung Disease”. (PIs: M Rabinovitch, MR Nicolls and MP Snyder). This included recruitment of candidates, oversight of training activities, ensuring compliance with NIH and Stanford policies, and acting as a liaison between the trainees and the Directors to facilitate effective communication.
Prior to joining Stanford, I was Associate Director (Scientific Development Administrator) at the Institute for Medicine and Engineering, directed by Dr. Peter Davies at the University of Pennsylvania. In this role, I was the liaison with federal funding agencies and organized multi-investigator program projects and training grants.
